6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Diagnosis: Latent ... Active TB: • ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Diagnosis: Latent ... Active TB: • ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Tuberculosis Infection ... and molecular diagnostic ... TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa # ... drugs #steps
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
organism identified, Strep ... 200: CMV, HSV Mycobacterial ... chest scan), CBC/diff ... Fungal, AFB), TB ... HIVAIDS #workup #diagnosis
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Note: Active TB ... AviumComplex #MAC #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology